Jaume C.
- Country
- Spain
- Department
- Servicio de Oncología Médica
Research Overview
- Phase 1b Study of OMTX705 in Patients with Advanced/Metastatic Pancreatic Adenocarcinoma
- Phase I/II Study of the Safety, Pharmacokinetics, and Efficacy of AZD9793 in Adults with Advanced or Metastatic GPC3-Expressing Hepatocellular Carcinoma
- Phase III Trial of BI 764532 Plus Carboplatin and Etoposide Versus Carboplatin and Etoposide in Previously Untreated DLL3-Positive Advanced Extrapulmonary Neuroendocrine Carcinoma
Data & Insights
Has run more than one trial at 101 of 231 partner sites.
Specializations
Neuroendocrine Cancer Research
The investigator specializes in treating various forms of neuroendocrine cancers, with particular focus on gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and advanced neuroendocrine carcinomas.
- Extra-pulmonary neuroendocrine carcinoma
- Large cell neuroendocrine carcinoma
- Well-differentiated GEP-NETs
Explores innovative therapeutic approaches for both high-grade and low-grade neuroendocrine tumors.
Colorectal and Anal Cancer
Focuses on treating locally advanced rectal cancer and squamous cell carcinoma of the anal canal, incorporating various therapeutic strategies.
- Advanced rectal cancer treatment
- Anal canal carcinoma therapy
- Neoadjuvant treatment approaches
Specializes in combined modality treatments for gastrointestinal malignancies.
Thyroid Cancer Treatment
Conducts research in advanced thyroid cancer treatments, particularly focusing on RET-mutant medullary thyroid cancer and radioiodine-refractory cases.
- Differentiated thyroid cancer
- Medullary thyroid cancer
- Progressive thyroid disease
Implements targeted therapeutic approaches for various thyroid cancer subtypes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.